Skip to the page

Data / Form D filings / Amplifyer Bio, Inc.

Amplifyer Bio, Inc.: Form D filing

Amplifyer Bio, Inc., a biotechnology company in Lexington, MA, filed a Form D with the SEC in 2024. The latest, on October 11, 2024, reports $7.1 million sold of a $7.1 million offering to 12 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
10 SHERMAN STREET, Lexington, MA, 02420
Phone
(617) 417-9885
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2040940

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 11, 2024New notice$7,078,494$7,078,49412Sep 27, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Eric K. HuangExecutive Officer, Director
J. Christopher LoveDirector
Thomas Christopher de VlaamDirector
Viktor A. AdalsteinssonDirector
Stanley Christopher LapidusDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Oct 7, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Amplifyer Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.